NOEMI PIMENTEL: Open Payments
NPI 1538643218 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,380 in 96 payments from 20 companies in 2025. Trend: 2023 $2,091 · 2024 $2,242 · 2025 $2,380
Food & beverage: $2,380
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $439 |
| Amgen Inc. | 15 | $366 |
| ABBVIE INC. | 16 | $269 |
| AstraZeneca Pharmaceuticals LP | 3 | $220 |
| PFIZER INC. | 10 | $201 |
| Axsome Therapeutics, Inc. | 3 | $146 |
| Astellas Pharma US Inc | 5 | $125 |
| SK Life Science, Inc. | 1 | $125 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $75 |
Products named: Wegovy, OTEZLA, BREZTRI, Auvelity, REPATHA, Veozah, XCOPRI, NURTEC ODT.
Industry payments across AZ — which companies pay providers there.
